• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UKPDS 风险引擎在新诊断 2 型糖尿病中的外部验证:需要新的 2 型糖尿病特异性风险方程。

External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.

机构信息

Corresponding author: Craig J. Currie,

出版信息

Diabetes Care. 2014 Feb;37(2):537-45. doi: 10.2337/dc13-1159. Epub 2013 Oct 2.

DOI:10.2337/dc13-1159
PMID:24089541
Abstract

OBJECTIVE

To evaluate the performance of the UK Prospective Diabetes Study Risk Engine (UKPDS-RE) for predicting the 10-year risk of cardiovascular disease end points in an independent cohort of U.K. patients newly diagnosed with type 2 diabetes.

RESEARCH DESIGN AND METHODS

This was a retrospective cohort study using routine health care data collected between April 1998 and October 2011 from ∼350 U.K. primary care practices contributing to the Clinical Practice Research Datalink (CPRD). Participants comprised 79,966 patients aged between 35 and 85 years (388,269 person-years) with 4,984 cardiovascular events. Four outcomes were evaluated: first diagnosis of coronary heart disease (CHD), stroke, fatal CHD, and fatal stroke.

RESULTS

Accounting for censoring, the observed versus predicted 10-year event rates were as follows: CHD 6.1 vs. 16.5%, fatal CHD 1.9 vs. 10.1%, stroke 7.0 vs. 10.1%, and fatal stroke 1.7 vs. 1.6%, respectively. The UKPDS-RE showed moderate discrimination for all four outcomes, with the concordance index values ranging from 0.65 to 0.78.

CONCLUSIONS

The UKPDS stroke equations showed calibration ranging from poor to moderate; however, the CHD equations showed poor calibration and considerably overestimated CHD risk. There is a need for revised risk equations in type 2 diabetes.

摘要

目的

评估英国前瞻性糖尿病研究风险引擎(UKPDS-RE)在预测英国新诊断为 2 型糖尿病患者 10 年心血管疾病终点风险方面的性能。

研究设计和方法

这是一项回顾性队列研究,使用 1998 年 4 月至 2011 年 10 月期间从参与临床实践研究数据链接(CPRD)的约 350 家英国初级保健机构收集的常规医疗保健数据。参与者包括年龄在 35 至 85 岁之间的 79966 名患者(388269 人年),其中有 4984 例心血管事件。评估了以下四个结局:首次诊断为冠心病(CHD)、中风、致命性 CHD 和致命性中风。

结果

考虑到删失,观察到的与预测的 10 年事件发生率如下:CHD 为 6.1%比 16.5%,致命性 CHD 为 1.9%比 10.1%,中风为 7.0%比 10.1%,致命性中风为 1.7%比 1.6%。UKPDS-RE 对所有四个结局均显示出中度区分能力,一致性指数值范围在 0.65 至 0.78 之间。

结论

UKPDS 中风方程的校准范围从差到中等;然而,CHD 方程的校准较差,并且大大高估了 CHD 风险。2 型糖尿病需要修订的风险方程。

相似文献

1
External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.UKPDS 风险引擎在新诊断 2 型糖尿病中的外部验证:需要新的 2 型糖尿病特异性风险方程。
Diabetes Care. 2014 Feb;37(2):537-45. doi: 10.2337/dc13-1159. Epub 2013 Oct 2.
2
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.弗雷曼特尔糖尿病研究中澳大利亚2型糖尿病患者的弗雷明汉心血管风险方程与英国前瞻性糖尿病研究心血管风险方程的比较。
Med J Aust. 2009 Feb 16;190(4):180-4. doi: 10.5694/j.1326-5377.2009.tb02684.x.
3
Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.弗雷明汉心血管风险方程和英国前瞻性糖尿病研究(UKPDS)风险评估模型对新诊断2型糖尿病患者冠心病的预后价值:一项英国研究的结果
Diabet Med. 2005 May;22(5):554-62. doi: 10.1111/j.1464-5491.2005.01494.x.
4
Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.评估马来西亚 2 型糖尿病患者的 10 年心血管疾病风险:弗雷明汉心血管风险与英国前瞻性糖尿病研究方程。
Asia Pac J Public Health. 2019 Oct;31(7):622-632. doi: 10.1177/1010539519873487. Epub 2019 Sep 19.
5
External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran.在伊朗国家糖尿病项目中识别出的2型糖尿病患者中对英国前瞻性糖尿病研究(UKPDS)风险评估模型进行外部验证。
J Diabetes Metab Disord. 2023 May 25;22(2):1145-1150. doi: 10.1007/s40200-023-01224-2. eCollection 2023 Dec.
6
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.验证 UKPDS 风险引擎在 2 型糖尿病患者中的外部有效性。
Diabetologia. 2011 Feb;54(2):264-70. doi: 10.1007/s00125-010-1960-0. Epub 2010 Nov 14.
7
Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).新诊断2型糖尿病患者致命性和非致命性冠心病及心血管疾病预测模型的开发:巴斯克地区前瞻性并发症和死亡率研究风险引擎(BASCORE)
Diabetologia. 2014 Nov;57(11):2324-33. doi: 10.1007/s00125-014-3370-1. Epub 2014 Sep 12.
8
Deficiencies of cardiovascular risk prediction models for type 1 diabetes.1型糖尿病心血管风险预测模型的缺陷。
Diabetes Care. 2006 Aug;29(8):1860-5. doi: 10.2337/dc06-0290.
9
Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.基于德国人群队列的 2 型糖尿病患者 UKPDS 结局模型 2 预测死亡和心血管事件的性能。
Pharmacoeconomics. 2019 Dec;37(12):1485-1494. doi: 10.1007/s40273-019-00822-4.
10
Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.10 年随访期间一般、糖尿病前期和糖尿病患者人群的冠心病风险预测:弗雷明汉、SCORE 和 UKPDS 风险函数的准确性:霍恩研究。
Diabetes Care. 2009 Nov;32(11):2094-8. doi: 10.2337/dc09-0745.

引用本文的文献

1
Prognostic models for cardiovascular and kidney outcomes in people with type 2 diabetes: living systematic review and meta-analysis of observational studies.2型糖尿病患者心血管和肾脏结局的预后模型:观察性研究的实时系统评价和荟萃分析
BMJ Med. 2025 Aug 14;4(1):e001369. doi: 10.1136/bmjmed-2025-001369. eCollection 2025.
2
External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran.在伊朗国家糖尿病项目中识别出的2型糖尿病患者中对英国前瞻性糖尿病研究(UKPDS)风险评估模型进行外部验证。
J Diabetes Metab Disord. 2023 May 25;22(2):1145-1150. doi: 10.1007/s40200-023-01224-2. eCollection 2023 Dec.
3
Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus.
评估 2 型糖尿病患者的动脉粥样硬化血栓形成风险。
J Am Coll Cardiol. 2023 Jun 27;81(25):2391-2402. doi: 10.1016/j.jacc.2023.04.031.
4
An Assessment of the Effect of Bariatric Surgery on Cardiovascular Disease Risk in the Chinese Population Using Multiple Cardiovascular Risk Models.使用多种心血管风险模型评估减重手术对中国人群心血管疾病风险的影响
Diabetes Metab Syndr Obes. 2023 Apr 12;16:1029-1042. doi: 10.2147/DMSO.S389346. eCollection 2023.
5
Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes.解读 2 型糖尿病患者近期心血管结局试验中的绝对风险降低和相对风险降低。
Curr Diab Rep. 2021 Nov 6;21(11):45. doi: 10.1007/s11892-021-01417-0.
6
Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan.在参加医疗保险优势计划的 2 型糖尿病患者中进行心血管风险预测模型和分层。
J Manag Care Spec Pharm. 2021 Nov;27(11):1579-1591. doi: 10.18553/jmcp.2021.27.11.1579.
7
Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea.预测中年 2 型糖尿病患者心肌梗死的发展:一项来自韩国全国基于人群队列研究的风险模型。
Endocrinol Metab (Seoul). 2020 Sep;35(3):636-646. doi: 10.3803/EnM.2020.704. Epub 2020 Sep 22.
8
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort.血清 tenascin-C 与 2 型糖尿病患者主要不良心血管事件和死亡的增加独立相关:一项法国前瞻性队列研究。
Diabetologia. 2020 May;63(5):915-923. doi: 10.1007/s00125-020-05108-5. Epub 2020 Feb 10.
9
Predicting the risk of stroke among patients with type 2 diabetes: a systematic review and meta-analysis of C-statistics.预测 2 型糖尿病患者中风风险:C 统计量的系统评价和荟萃分析。
BMJ Open. 2019 Aug 30;9(8):e025579. doi: 10.1136/bmjopen-2018-025579.
10
New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population.新的糖尿病合并与不合并冠心病风险预测模型:在日本人群 3 年纵向数据库中对 Framingham 风险评分和 Suita 评分的评估。
Sci Rep. 2019 Feb 26;9(1):2813. doi: 10.1038/s41598-019-39049-w.